Patents Assigned to Pentech Pharamaceticals, Inc.
  • Patent number: 5939094
    Abstract: Dosage forms for the transdermal administration of apomorphine are described. The dosage forms are water-soluble gel compositions that contain apomorphine, optionally together with a permeation enhancer, or transdermal patches.
    Type: Grant
    Filed: October 8, 1996
    Date of Patent: August 17, 1999
    Assignee: Pentech Pharamaceticals, Inc.
    Inventors: Franck Durif, Ragab El-Rashidy